Nursing observation of 40 cycles of Opdivo in an elderly patient with advanced heterochronous esophageal cancer who tested negative for programmed death ligand 1
10.3760/cma.j.issn.1672-7088.2020.07.014
- VernacularTitle:一例程序性死亡蛋白-配体1检测阴性晚期异时性食管癌老年患者应用纳武单抗40周期的护理观察
- Author:
Hong KUANG
1
;
Haiyan SHI
;
Liang LIAO
Author Information
1. 解放军总医院第二医学中心暨国家老年疾病临床医学中心消化内科三病区，北京 100048
- From:
Chinese Journal of Practical Nursing
2020;36(7):550-552
- CountryChina
- Language:Chinese
-
Abstract:
Objective:To observe the effect of long cycle application of Opdivo in patients with esophageal cancer whose programmed death ligand 1(PD-L1) test was negative and the nursing care of its related adverse reactions.Methods:For an elderly patient with advanced heterochronous esophageal cancer with only 40 cycles of Opdivo and negative PD-L1, detailed individualized nursing measures were made from the aspects of medication management, psychological guidance and observation of adverse reactions.Results:The vital signs of the patients were stable, the KPS score was increased from 60 to 80, the carcinoembryonic antigen was reduced from 15.36 μg/L to 9.45 μg /L, and the adverse reactions such as immune dermatitis and hypothyroidism were relieved.Conclusions:The nursing experience of patients treated with Opdivo for a long period has been obtained, and the corresponding nursing evidence support has been provided for the clinical application of navumab in the treatment of tumor.
